Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and gain-of-function drug therapy, to meet the urgent need for treatments that have the potential to restore liver function and prevent the progression to liver failure across multiple liver diseases that are untreatable or poorly treated today. Ambys was launched in 2018 by Third Rock Ventures and Takeda Pharmaceuticals with $140M in starting capital and is headquartered in South San Francisco, Calif.
Location: United States, California, Redwood City
Member count: 51-200
Total raised: $187M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | Takeda Ven... | takeda.com |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 21.12.2021 | Series A | $47M | - | - |
| 08.08.2018 | Series A | $140M | Takeda Ven... | fiercebiot... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 13.12.2018 | Third Rock... | Trained as a lawyer, Jeff Jonk... | - | Endpoints ... | endpts.com... |
| 12.08.2018 | Ambys Medi... | REDWOOD CITY, Calif.--(BUSINES... | - | - | citybizlis... |
| 10.08.2018 | Term Sheet... | MORE DEBT Happy Friday, Term ... | - | - | fortune.co... |
| 08.08.2018 | Liver-focu... | Third Rock Ventures is debutin... | Biotech | - | fiercebiot... |
| 08.08.2018 | Ambys Medi... | Ambys Medicines, a Redwood Cit... | USA | - | finsmes.co... |